Get started
OSTEOPORE LIMITEDOO

OSTEOPORE LIMITED

0.014AUDD
−0.001−6.67%
At close at 05:44 GMT
AUD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

OSX fundamentals

Key facts

Market capitalization‪2.60 M‬AUD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.03AUD
Founded2018
Employees (FY)—
CEOYu Jing Lim
Websiteosteopore.com
About

Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. It engages in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Its products include Osteoplug and Osteomesh. The company was founded in November 2003 and is headquartered in West Perth, Australia.

Ownership
‪‪173.43 M‬‬
Free Float shares
‪‪158.60 M‬‬ (91.45%)
Closely held shares
‪‪14.83 M‬‬ (8.55%)
Free Float shares
‪‪158.60 M‬‬ (91.45%)
Closely held shares
‪‪14.83 M‬‬ (8.55%)
Capital structure
Market cap
‪‪2.60 M‬‬
Debt
‪‪1.33 M‬‬
Cash & equivalents
‪‪638.50 K‬‬
Enterprise value
‪‪3.29 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.60 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
0.63x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
0.63x
Valuation ratios
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪3.00‬
‪6.00‬
‪9.00‬
‪12.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−300%‬
‪−250%‬
‪−200%‬
‪−150%‬
‪−100%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.80 M‬‬
‪‪−900.00 K‬‬
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−1.80 M‬‬
‪‪−900.00 K‬‬
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
3D-printed Biomimetic and Bioresorbable Implants
By country
Period: 2024
South Korea
Singapore
Australia

Dividends

Dividend yield, history and sustainability

No dividends
OSX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−2.40 M‬‬
‪‪−1.20 M‬‬
‪0.00‬
‪‪1.20 M‬‬
‪‪2.40 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪700.00 K‬‬
‪‪1.40 M‬‬
‪‪2.10 M‬‬
‪‪2.80 M‬‬
Assets
Liabilities